Table 4.
Analysis of ablation outcomes among the different subgroups.
|
Patients
+AF (n = 24) |
Patients
–AF (n = 48) |
P-value |
Typical
AFL +AF (n = 17) |
Typical
AFL –AF (n = 28) |
P-value |
Atypical
AFL +AF (n = 7) |
Atypical
AFL –AF (n = 20) |
P-value |
Typical
AFL –AF (n = 28) |
Atypical
AFL –AF (n = 20) |
P-value | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Recurrence | 11/24 (45.8%) | 12/48 (25.0%) | 0.074 | 9/17 (52.9%) | 4/28 (14.3%) | 0.006 | 2/7 (28.6%) | 8/20 (40.0%) | 0.311 | 4/28 (14.3%) | 8/20 (40.0%) | 0.043 |
| Time to recurrence (months) | 12.1 ± 7.1 | 14.4 ± 12.8 | 0.592 | 11.8 ± 6.7 | 17.5 ± 19.1 | 0.597 | 13.5 ± 12.0 | 12.9 ± 9.6 | 0.938 | 17.5 ± 19.1 | 12.87 ± 9.53 | 0.673 |
| Type of recurrent arrhythmia | ||||||||||||
| Typical AFL | 3/24 (12.5%) | 0/48 (0) | 0.012 | 2/17 (11.9%) | 0/28 (0) | 0.063 | 1/7 (0) | 0/20 (0) | 0.085 | 0/28 (0) | 0/20 (0) | – |
| Atypical AFL | 4/24 (16.7%) | 5/48 (10.4%) | 0.450 | 3/17 (17.6%) | 1/28 (3.6%) | 0.108 | 1/7 (0%) | 4/20 (20.0%) | 0.738 | 1/28 (3.6%) | 4/20 (20.0%) | 0.066 |
| AF | 3/24 (12.5%) | 7/48 (14.6%) | 0.810 | 3/17 (17.6%) | 3/28 (10.7%) | 0.507 | 0/7 (10.7%) | 4/20 (20.0%) | 0.200 | 3/28 (10.7%) | 4/20 (20.0%) | 0.369 |
| Focal AT | 1/24 (4.2%) | 0/48 (0) | 0.154 | 1/17 (5.9%) | 0/28 (0) | 0.194 | 0/28 (0) | 0/20 (0) | NA | 0/28 (0) | 0/20 (0) | – |